Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

The Global Computed Tomography Devices Market to Witness Upsurge in Growth at a CAGR of ~6% by 2027 | DelveInsight

Published

on

<!– Name:DistributionId Value:8787701 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1204938 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:c8626559-5d02-4aeb-9295-f9b7599d7759 –>

New York, USA, March 14, 2023 (GLOBE NEWSWIRE) — The Global Computed Tomography Devices Market to Witness Upsurge in Growth at a CAGR of ~6% by 2027 | DelveInsight

As per DelveInsight analysis in the computed tomography devices market, the rise in the incidence of chronic diseases such as cardiovascular, oncological, and others, along with the rapid advancements in technology are likely to propel the global computed tomography devices market.

DelveInsight’s Computed Tomography Devices Market Insights report provides the current and forecast market analysis, individual leading computed tomography devices companies’ market shares, challenges, computed tomography devices market drivers, barriers, and trends, and key computed tomography devices companies in the market.

Key Takeaways from the Computed Tomography Devices Market Report

  • As per DelveInsight estimates, North America is anticipated to dominate the global computed tomography devices market during the forecast period. 
  • Notable computed tomography devices companies such as General Electric Company, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, NeuroLogica Corp. (Samsung Electronics), Shimadzu Corp., Thermo Fisher Scientific, Xoran Technologies LLC, Trivitron Healthcare, Neusoft Medical Systems Co., Ltd., Shenzhen Anke High-Tech Co. Ltd., Shenzhen Basda Medical Apparatus Co. Ltd., PerkinElmer Inc., ICRco, Inc., MARS Bioimaging Ltd., United Imaging Healthcare Co., Ltd., SternMed GmbH, MinFound Medical Systems Co., Ltd, MR Solutions, and several others are currently operating in the computed tomography devices market.
  • In January 2023, GE HealthCare announced it had entered into an agreement to acquire IMACTIS, an innovator in the rapidly growing field of computed tomography (CT) interventional guidance across various care areas.
  • In October 2022, NeuroLogica, a subsidiary of Samsung Electronics, received CE mark approval from the European Union (EU) for its new Elite mobile computed tomography (CT) systems.
  • In June 2022, Siemens Healthineers received FDA approval for its latest scanner, which combines SPECT and CT imaging into a relatively small package.
  • Thus, owing to such developments in the market, rapid growth will be observed in the computed tomography devices market during the forecast period.

To read more about the latest highlights related to the computed tomography devices market, get a snapshot of the key highlights entailed in the Global Computed Tomography Devices Market Report 

Computed Tomography Devices Overview

According to the US Food and Drug Administration (FDA), computed tomography (CT) is a device that helps physicians diagnose a variety of conditions by producing images of internal organs and body structures. A CT scanner is an x-ray machine that uses a computer to generate cross-sectional views and, if necessary, three-dimensional images of the body’s internal organs and structures.

Computed Tomography Devices Market Insights 

The global computed tomography devices market is studied geographically for North America, Europe, Asia-Pacific, and the Rest of the World. North America currently leads the global market in terms of revenue share and is expected to maintain its computed tomography devices market position during the study period, owing to various factors such as rising cancer cases, increased CT utilization, technical advancements, strong financial incentives, and others, which are expected to aid the growth of the North American computed tomography devices market.

In addition to the increase in the cases of chronic diseases like cancer, another factor responsible for the growth of the computed tomography devices market is the increased emphasis on product development activities and the high interest of device manufacturers, which further aid in the growth of regional computed tomography devices markets. For example, in June 2022, Siemens Healthineers received FDA approval for its latest scanner, which combines SPECT and CT imaging into a relatively small package.

These kinds of product launches and approvals in the local markets by key players in computed tomography devices may drive product demand in the computed tomography devices market. Therefore, the interplay of factors, such as the presence of a large patient population along with the encouragement of new product launches in the region, is expected to boost the North American computed tomography devices market during the forecast period. 

To know more about why North America is leading the market growth in the computed tomography devices market, get a snapshot of the Computed Tomography Devices Market Outlook

Computed Tomography Devices Market Dynamics 

The global computed tomography devices market is projected to witness considerable growth due to an upsurge in the cases of severe chronic diseases such as cardiovascular, oncological and others, rapid technological advancements in product design, increased awareness of early diagnosis, coupled with the rise in geriatric population, is expected to bolster the growth of the computed tomography devices market during the forecast period from 2022–2027.

However, high costs and ionizing radiation doses delivered during scanning may be limiting factors in the growth of the computed tomography devices market.

Additionally, the unprecedented COVID-19 pandemic has boosted the growth of the computed tomography devices market. CT scans, along with laboratory tests, are one of the diagnostic tools for COVID-19. Background chest CT, for example, was used to diagnose coronavirus disease and was a necessary complement to reverse-transcription polymerase chain reaction (RT-PCR) tests. During the pandemic, this resulted in an increase in demand for computed tomography devices. Furthermore, the economic recovery process, with the easing of lockdown restrictions and the return of normalcy in the post-pandemic economic landscape, has resulted in the resumption of healthcare services for other modalities as well, maintaining demand for these products in the computed tomography devices market.

Get a sneak peek at the computed tomography devices market dynamics @ Computed Tomography Devices Market Dynamics Analysis

Report Metrics Details
Coverage Global
Study Period 2019–2027
Base Year 2021
Computed Tomography Devices Market CAGR ~6%
Projected Computed Tomography Devices Market Size by 2027 USD 8.87 Billion
Key Computed Tomography Devices Companies General Electric Company, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, NeuroLogica Corp. (Samsung Electronics), Shimadzu Corp., Thermo Fisher Scientific, Xoran Technologies LLC, Trivitron Healthcare, Neusoft Medical Systems Co., Ltd., Shenzhen Anke High-Tech Co. Ltd., Shenzhen Basda Medical Apparatus Co. Ltd., PerkinElmer Inc., ICRco, Inc., MARS Bioimaging Ltd., United Imaging Healthcare Co., Ltd., SternMed GmbH, MinFound Medical Systems Co., Ltd, MR Solutions, among others

Computed Tomography Devices Market Assessment

  • Computed Tomography Devices Market Segmentation
    • Market Segmentation By  Type: Stationary CT Scanners, Portable CT Scanners
    • Market Segmentation By  Modality: O-Arm, C-Arm
    • Market Segmentation By  Technology: Low End, Mid-End, High End
    • Market Segmentation By  Application: Oncology, Cardiology, Neurology, Others
    • Market Segmentation By End User: Hospitals, Diagnostic Imaging Centres, Others
    • Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
  • Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the computed tomography devices market are set to emerge as the trendsetter explore @ Computed Tomography Devices Companies 

Table of Contents 

1 Report Introduction
2 Executive summary
3 Regulatory and Patent Analysis
4 Key Factors Analysis
5 Porter’s Five Forces Analysis
6 COVID-19 Impact Analysis on Computed Tomography Devices Market
7 Computed Tomography Devices Market Layout
8 Global Company Share Analysis – Key 3-5 Companies
9 Computed Tomography Devices Market Company and Product Profiles
10 Project Approach
11 About DelveInsight

Interested in knowing the computed tomography devices market by 2027? Click to get a snapshot of the Computed Tomography Devices Market Trends

Related Reports

Optical Coherence Tomography Market

Optical Coherence Tomography Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key optical coherence tomography companies, including Abbott, Terumo Corporation, ZEISS Group, Leica Microsystems, CANON MEDICAL SYSTEMS EUROPE B.V, Lumedica, among others.

Positron Emission Tomography Market

Positron Emission Tomography Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key positron emission tomography companies, including General Electric Company, Mediso Ltd., Bruker Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, Positron Corporation, Shimadzu Corp., among others.

Magnetic Resonance Imaging Devices Market

Magnetic Resonance Imaging Devices Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key magnetic resonance imaging devices companies, including General Electric Company, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., among others.

Cardiovascular Imaging Equipment Market

Cardiovascular Imaging Equipment Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cardiovascular imaging equipment companies, including oshiba, GE Healthcare, Siemens Healthcare, Philips Healthcare, Epsilon Imaging, among others.

Cancer Therapy Market

Cancer Therapy Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cancer therapy companies, including GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, Sanofi, among others.

Intratumoral Cancer Therapies Market

Intratumoral Cancer Therapies Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, along with emerging drugs and key intratumoral cancer therapies companies, including  Daiichi Sankyo, Amgen, Idera Pharmaceuticals, Philogen, among others.

Other Trending Reports

Treatment Resistant Depression Market | Advanced Renal Cell Carcinoma Market | Brain Cancer Market | Centronuclear Myopathy Market | Head And Neck Squamous Cell Carcinoma Market | Acquired Immunodeficiency Syndrome Market | Acute Intermittent Porphyria Market | Neurovascular Devices Market | Defibrillators Market | Ventricular Hypertrophy Market | Urolithiasis Market | Alopecia Areata Market | Autonomic Dysfunction Market | Acute Ischemic Stroke Ais Market | Adenoid Cystic Carcinoma Market | Aspergillosis Market | Biliary Atresia Market | Biliary Tumor Market | Chronic Inducible Urticaria Market | Chronic Insomnia Market | Critical Limb Ischemia Market | Endometriosis Pain Market | Generalized Anxiety Disorder Gad Market | Hallux Valgus Market | Hemophilia B Market | Immunologic Deficiency Syndrome Market | Neuroblastoma Market | Neuromodulation Devices Market | Neurovascular Thrombectomy Devices Market | Osteosarcoma Market | Pemphigus Vulgaris Market | Progressive Familial Intrahepatic Cholestasis Market | Pruritus Market | Radiation Toxicity Market | Pulmonary Hypertension Associated With Interstitial Lung Disease Market | Cluster Headaches Market | Foot And Ankle Devices Market | Intravenous Immunoglobulin Market | Bile Duct Neoplasm Market | Blood Glucose Monitoring Systems Market | Rett Syndrome Market | Tissue Heart Valves Market | Cardiac Biomarkers Testing Devices Market | Subscription Healthcare | Hepatorenal Syndrome Market | Central Venous Catheters Market | Continuous Renal Replacement Therapy Machines Market | Nonalcoholic Steatohepatitis Market | Necrotizing Enterocolitis Market | Cardiac Amyloidosis Market | Artificial Iris Market | Aortic Aneurysm Stent Grafts Market | Polypoidal Choroidal Vasculopathy Market | Adrenal Crisis Market | Hearing Implants Market | Image Guided Surgery Devices Market | Angioedema Market | Bladder Cancer Market

Related Healthcare Blogs

Upcoming Oncological Drugs

Upcoming Cardiovascular Diseases Drugs

Key Companies in the Cardiology Segment

Heart Failure Market

Top Cardiac Devices in the Market

Related Healthcare Services

Healthcare Consulting

Healthcare Competitive Intelligence Services

Healthcare Asset Prioritization Services

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.  


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

CGTN: 3rd CMG Forum in Beijing discusses AI development

Published

on

cgtn:-3rd-cmg-forum-in-beijing-discusses-ai-development

BEIJING, May 1, 2024 /PRNewswire/ — Focusing on the development of AI, the third CMG Forum was held on Monday in Beijing.

Li Shulei, a member of the Political Bureau of the Communist Party of China (CPC) Central Committee and the head of the Publicity Department of the CPC Central Committee, attended the opening of the event and delivered a speech.
Guests at the forum stressed the role of media in promoting the innovative application of AI as well as its governance.
Efforts should also be made to boost the development of AI in creating positive, healthy, diverse and high-quality content, so that AI can become a force for good and benefit mankind, they agreed.
They also called on media to accelerate intelligent transformation and help bridge international exchanges and cooperation on the governance of AI to facilitate its healthy, orderly and safe development.
Hosted by China Media Group (CMG), the forum attracted more than 200 participants from international organizations, media, think tanks and multinational companies.
“Innovation and breakthroughs in science and technology not only guide the development and progress of human civilization, but also bring uncertainty to the changing world,” said Shen Haixiong, vice minister of the Publicity Department of the CPC Central Committee and president of CMG. He called for efforts to jointly create valuable and responsible artificial intelligence.
AI technology is affecting every aspect of our lives. Thomas Bach, president of the International Olympic Committee (IOC), stated in a video speech that CMG has always been a partner of the IOC, bringing the charm of the Olympic Games to hundreds of millions of Chinese viewers. He said the IOC invites CMG to work together for the creation of a future with the application of AI in Olympic sports.
“From ancient inventions such as silk, printing and the compass to modern technological advances such as robotics, telecommunications and green technology, China has always been committed to innovation and creation,” said Daren Tang, director general of the World Intellectual Property Organization (WIPO). He said WIPO pays close attention to ensuring a balance between the opportunities and risks of artificial intelligence and is committed to strengthening cooperation to ensure that artificial intelligence is properly used.
https://news.cgtn.com/news/2024-04-30/3rd-CMG-Forum-in-Beijing-discusses-AI-development-1tdDcXvCexG/p.html

View original content:https://www.prnewswire.co.uk/news-releases/cgtn-3rd-cmg-forum-in-beijing-discusses-ai-development-302133410.html

Continue Reading

Artificial Intelligence

Trianz Appoints Sridhar Kannan as Practice Leader – Digital, Elevating its Leadership in the Global Digital Transformation Space

Published

on

trianz-appoints-sridhar-kannan-as-practice-leader-–-digital,-elevating-its-leadership-in-the-global-digital-transformation-space

SANTA CLARA, Calif., May 1, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Sridhar Kannan as Practice Leader – Digital. With over 25 years of extensive experience in technology and business leadership, Sridhar joins Trianz to lead the expansion of Trianz’s Digital Practice, forging strategic alliances and expanding the business footprint.

Sridhar’s appointment comes at a transformative phase for Trianz as it solidifies its commitment to redefining the digital landscape with an “IP Led” model. This strategic shift is powered by Trianz’s cutting-edge hyper-automated platforms, Concierto.Cloud, Extrica.AI, and Pulse, driving industry-leading transformations in cloud, data and analytics, AI, and the digital workplace. Sridhar’s visionary leadership in technology-led business transformations across diverse sectors will be instrumental in leveraging IP-led models and innovative methodologies to position Trianz at the forefront of digital transformation.
“We are thrilled to welcome Sridhar Kannan to the Trianz family,” said Seshi Vanguru, Chief Revenue Officer at Trianz. “His appointment marks a significant stride in Trianz’s journey toward innovation and excellence. Sridhar’s wealth of experience and exceptional leadership skills will elevate our Digital Practice to new heights, reaffirming our commitment to delivering exceptional value to our clients.”
Sridhar is recognized as a client-focused technology and business transformation executive with a remarkable track record of helping Banking and Financial Services organizations in business transformation and product innovation using applications, cloud, data, and digital solutions. His extensive prior experience at industry giants such as Wipro, Cognizant, and Infosys include successfully leading Fortune 10 global client relationships and implementing transformative solutions across Banking, Financial Services, and Healthcare industries. Sridhar is highly regarded for his ability to lead global cross-functional teams, foster collaboration, and achieve aggressive business goals while consistently delivering high levels of client satisfaction.
“I am deeply honored to join Trianz and contribute to its mission of shaping the future through digital transformation,” said Sridhar. “Together, we will push the boundaries of what’s possible and drive meaningful impact for our clients in this rapidly evolving digital landscape.”
Based out of Minnesota, US, Sridhar has steered numerous clients towards success through the strategic application of Digital, Cloud, Product Engineering, Data, AI, and Application services, making him a seasoned strategist in today’s dynamic digital landscape. His appointment marks a significant milestone in Trianz’s journey to nurturing talent and delivering world-class solutions.
About Trianz
Trianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our “IP Led Transformations” approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media Team : [email protected]+1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/trianz-appoints-sridhar-kannan-as-practice-leader–digital-elevating-its-leadership-in-the-global-digital-transformation-space-302132835.html

Continue Reading

Artificial Intelligence

2024 World Digital Health Forum: AI at the Forefront of Healthcare Innovation

Published

on

2024-world-digital-health-forum:-ai-at-the-forefront-of-healthcare-innovation

BEIJING, May 1, 2024 /PRNewswire/ — Hosted by Tsinghua University and its partners, the 2024 World Digital Health Forum emerged as a cornerstone of the ZGC Forum’s AI Theme Day. Held in Beijing’s tech-centric Haidian District, this event attracted over 700,000 online attendees from around the globe. The forum was a collaboration with the Haidian District People’s Government, the Chinese Institute of Electronics, Tsinghua University School of Clinical Medicine, and the China Association for the Promotion of Science and Technology Industrialization, highlighting pioneering innovations and fostering global partnerships to enhance patient well-being.

The Forum showcased an impressive lineup of speakers, each contributing unique insights into the evolving digital health landscape. Notable among them were Dong Jiahong, President of the Academic Committee at Tsinghua University School of Clinical Medicine, and Andrew Chi-Chih Yao, Dean of the Institute for Interdisciplinary Information Sciences at Tsinghua University and the recipient of the 2000 Turing Award. Speeches from Mustafa Shehu, President of the World Federation of Engineering Organizations, and Martin Taylor, WHO Representative in China, enriched the overall perspectives presented at the Forum. Attended by 19 academicians and 70 deans, the event spurred extensive discussions on the future of healthcare in an era increasingly shaped by AI.
A highlight of the Forum was the release of the “Tsinghua Urban Health Index,” which provides a comprehensive assessment of health services across 296 Chinese cities, establishing a new benchmark in health metrics to aid governmental and regional health planning. In addition, the “World Digital Health Forum Declaration” was ratified, laying down a robust framework for universal access to healthcare, and underscoring the importance of collaboration, ethical standards, and innovation-driven changes in global healthcare practices.
The Principal’s Dialogue, a pivotal segment of the Forum, brought together leaders from premier universities to discuss advancing new productive forces and constructing a robust medical talent-cultivating system. During this session, Tsinghua University highlighted its plans to develop an integrated education system connecting hospitals, medical schools, and research institutions. This approach aims to nurture students who are not only skilled in interdisciplinary collaboration but also deeply grounded in humanistic values. The dialogue explored the transformative impact of AI and digital technologies in enhancing diagnostic accuracy and treatment efficacy. They particularly noted the potential for these technologies to enable real-time, remote medical guidance in regions with limited medical resources, enhancing a balanced healthcare delivery nationwide. Additionally, panelists stressed the importance of maintaining an ethical and patient-centric approach in developing and adopting digital health technologies. They advocated for dynamic systems that can adapt to the evolving needs of patients throughout their lifetimes.
The 2024 World Digital Health Forum facilitated high-level discussions and catalyzed future innovations in the digital health sphere. It aims to advance the digital health industry, integrate digital technologies with health and life sciences, and foster new developments in health careers. In doing so, it seeks to enhance global health outcomes and contribute to the collective well-being of communities globally.
Media Enquiries: 
Global Communication Office, [email protected]
Photo – https://mma.prnewswire.com/media/2402661/Tsinghua_University.jpg

View original content:https://www.prnewswire.co.uk/news-releases/2024-world-digital-health-forum-ai-at-the-forefront-of-healthcare-innovation-302133294.html

Continue Reading

Trending